AZNNEUTRAL

Debt-to-Equity Ratio

0.68x

Higher than 62% of Healthcare sector peers

Updated 19h ago

Sector Performance

62th percentile

AZN

0.68x

Sector Median

0.43x

Sector Avg

0.81x

📊

Deep Analysis

AstraZeneca’s debt-to-equity ratio of 0.68x means that for every $1 of shareholder equity, the company has $0.68 in debt, indicating a moderate use of borrowing to finance its operations.

This ratio sits above the healthcare sector median of 0.43x, placing AstraZeneca in the 62nd percentile among peers — meaning its leverage is higher than about 62% of the sector. The year-over-year change is not available, but the quarter-over-quarter change shows a -5.6% decline, moving from 0.72x to 0.68x, reflecting a reduction in debt relative to equity over the last quarter. While the current level of 0.68x is above the sector median, the downward trend suggests the company is deleveraging, which can reduce financial risk. For an investor, the above-median leverage warrants attention, but the recent decline tempers concerns about excessive debt. This metric aligns with the overall NEUTRAL verdict, as the elevated level relative to peers introduces caution, while the improving trend does not signal clear strength or weakness.

Frequently Asked Questions

What does the Debt-to-Equity Ratio tell investors about AZN?

Shows how much a company is financing its operations through debt vs shareholder funds. High D/E can amplify returns — and losses.

How is the Debt-to-Equity Ratio calculated?

Debt-to-Equity Ratio is calculated as: Total Debt / Shareholders' Equity.

How does AZN's Debt-to-Equity Ratio compare to its sector?

AZN's Debt-to-Equity Ratio of 0.68x compares to a Healthcare sector median of 0.43x, placing it in the 62th percentile.

Who are AZN's closest peers by Debt-to-Equity Ratio?

The closest Healthcare peers by Debt-to-Equity Ratio include: BIIB (0.34x), BIO (0.18x), NTRA (0.14x), NTLA (0.13x), RMD (0.13x).

The Formula

Total Debt / Shareholders' Equity

Why It Matters

Shows how much a company is financing its operations through debt vs shareholder funds. High D/E can amplify returns — and losses.

Master AZN's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full AZN research report

Free account — no credit card

AZN

0.68x

Sector Median

0.43x

Sector Avg

0.81x

How AZN's Debt-to-Equity Ratio compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.